What is the role of molecular markers in the treatment of pancreatic cancer?

Updated: Oct 02, 2020
  • Author: Tomislav Dragovich, MD, PhD; Chief Editor: N Joseph Espat, MD, MS, FACS  more...
  • Print

The poor response to therapy has spurred research into precision medicine for pancreatic cancer. The PRIMUS-004 trial will use cell lines and organoids generated from patients with pancreatic cancer to develop new molecular markers to predict response to agents that target DNA damage. [65]

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!